Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $130

Benzinga · 2d ago
Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $110 to $130.